The influence of sodium on pathophysiology of multiple sclerosis

被引：19
|
作者：
Zostawa, Jacek [1 ]
Adamczyk, Jowita [1 ]
Sowa, Pawel [2 ]
Adamczyk-Sowa, Monika [1 ]
机构：
[1] Med Univ Silesia, Dept Neurol Zabrze, Ul 3 Go Maja 13-15, PL-41800 Zabrze, Poland
[2] Med Univ Silesia, Dept Otorhinolaryngol & Oncol Laryngol, Ul C Sklodowskiej 10, PL-41800 Zabrze, Poland
来源：
NEUROLOGICAL SCIENCES | 2017年 / 38卷 / 03期
关键词：
Sodium chloride intake; Multiple sclerosis; Environmental factors in MS; VGSCs; EPSTEIN-BARR-VIRUS; GATED NA+ CHANNELS; VITAMIN-A SUPPLEMENTATION; PATHOGENIC T(H)17 CELLS; DOUBLE-BLIND; DISEASE PROGRESSION; TETRODOTOXIN-RESISTANT; MECHANICAL ALLODYNIA; FEBRILE SEIZURES; IMMUNE-RESPONSE;
D O I：
10.1007/s10072-016-2802-8
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Multiple sclerosis (MS) is a chronic, inflammatory, autoimmune disease of the central nervous system, and is an important cause of disability in young adults. In genetically susceptible individuals, several environmental factors may play a partial role in the pathogenesis of MS. Some studies suggests that high-salt diet (> 5 g/day) may contribute to the MS and other autoimmune disease development through the induction of pathogenic Th17 cells and pro-inflammatory cytokines in both humans and mice. However, the precise mechanisms of pro-inflammatory effect of sodium chloride intake are not yet explained. The purpose of this review was to discuss the present state of knowledge on the potential role of environmental and dietary factors, particularly sodium chloride on the development and course of MS.
引用
收藏
页码：389 / 398
页数：10
相关论文
共 50 条
  • [21] Pathophysiology of urinary dysfunction in multiple sclerosis
    Di Benedetto, P.
    Giorgini, T.
    Delneri, C.
    Biasutti, E.
    NEUROLOGICAL SCIENCES, 2006, 27 (Suppl 4) : S320 - S322
  • [22] Pain and Multiple Sclerosis: Pathophysiology and Treatment
    Claudio Solaro
    Erika Trabucco
    Michele Messmer Uccelli
    Current Neurology and Neuroscience Reports, 2013, 13
  • [23] Pathophysiology of micturition disturbances in multiple sclerosis
    Fowler, CJ
    SEXUALITY AND DISABILITY, 1996, 14 (01) : 7 - 12
  • [24] Advances in the management of multiple sclerosis symptoms: pathophysiology and assessment of spasticity in multiple sclerosis
    Tintore, Mar
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2015, 5 (06) : 15 - 17
  • [25] Are astrocytes central players in the pathophysiology of multiple sclerosis?
    De Keyser, J
    Zeinstra, E
    Frohman, E
    ARCHIVES OF NEUROLOGY, 2003, 60 (01) : 132 - 136
  • [26] Fatigue in multiple sclerosis: pathophysiology and emergent interventions
    Ayache, S. S.
    Chalah, M. A.
    ARCHIVES ITALIENNES DE BIOLOGIE, 2018, 156 (04): : 149 - 152
  • [27] Pathophysiology and treatment of fatigue in multiple sclerosis.
    Boërio, D
    Lefaucheur, JP
    Hogrel, JY
    Créange, A
    REVUE NEUROLOGIQUE, 2006, 162 (03) : 311 - 320
  • [28] Impact of apolipoprotein E on the pathophysiology of multiple sclerosis
    Biernacka-Lukanty, Justyna
    Tokarz-Kupczyk, Elzbieta
    Wygladalska-Jernas, Halina
    Michalowska-Wender, Grazyna
    Wender, Mieczyslaw
    PHARMACOLOGICAL REPORTS, 2009, 61 (06) : 1238 - 1238
  • [29] Impact of B cells to the pathophysiology of multiple sclerosis
    Borros M. Arneth
    Journal of Neuroinflammation, 16
  • [30] Fatigue in multiple sclerosis - Definition, pathophysiology and treatment
    Krupp, LB
    CNS DRUGS, 2003, 17 (04) : 225 - 234
12345